Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new delineation method research of the clinical target volume for pancreatic cancer adjuvant radiotherapy.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2019
Same author

Efficacy and safety of sirolimus in the treatment of blue rubber bleb naevus syndrome in paediatric patients.

Clinical and experimental dermatology·2019
Same author

[Hotspot issue of clinical practice of multiple arterial grafting in coronary artery bypass surgery in China].

Zhonghua yi xue za zhi·2019
Same author

Differential MicroRNA Expressions in Human Peripheral Blood Mononuclear Cells Are Predictive of Renal Allograft Function.

Transplantation proceedings·2019
Same author

Increased Dental Use May Affect Changes in Treated and Untreated Dental Caries in Young Children.

JDR clinical and translational research·2019
Same author

[The comparison among the guidelines for the diagnosis and treatment of hepatocellular carcinoma in China, AASLD and EASL].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2019
Same journal

[Transitional and clinical practice pathways for whole-course management of hepatocellular carcinoma in the infectious diseases department].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same journal

[Natural history and risk factors of metabolic associated fatty liver disease in Chinese cohorts].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same journal

[Analyzing research advances in single-cell sequencing technology for immunopathological mechanisms in acute-on-chronic liver failure].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same journal

[Advances in the diagnosis and treatment of patients with multidrug-resistant bacterial infections combined with severe liver disease].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same journal

[Dietary serine supplementation inhibits the hepatic macrophage AKT/mTOR pathway and improves primary biliary cholangitis].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same journal

[Clinical study on the efficacy of Wuling capsules combined with nucleos(t)ide analogues in the treatment of low-level viremia patients with chronic hepatitis B].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
See all related articles

Related Experiment Video

Updated: Jun 29, 2025

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.0K

[Research progress on pseudocirrhosis].

X Y Zhao1, L Wei1

  • 1Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|April 7, 2024
PubMed
Summary
This summary is machine-generated.

Pseudocirrhosis, a condition in liver metastasis patients, presents with portal hypertension symptoms and unique imaging findings. This review explores its prevalence, causes, diagnosis, and impact on survival.

Keywords:
Breast cancerChemotherapyHistologyImagingPseudocirrhosis

More Related Videos

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

604
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

20.4K

Related Experiment Videos

Last Updated: Jun 29, 2025

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.0K
Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

604
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

20.4K

Area of Science:

  • Hepatology
  • Oncology
  • Pathology

Background:

  • Pseudocirrhosis frequently complicates liver metastases from malignant tumors, mimicking liver cirrhosis.
  • It manifests with portal hypertension symptoms (edema, ascites, bleeding) and characteristic imaging findings like nodules and caudate lobe enlargement.
  • Histological features include diffuse tumor infiltration, fibrosis, vascular thrombosis, and pseudolobule formation.

Approach:

  • This review synthesizes current research from case reports, observational studies, and meta-analyses.
  • It examines the prevalence, etiology, pathogenesis, diagnostic challenges, treatment strategies, and prognostic implications of pseudocirrhosis.
  • The review aims to clarify the unclear relationships between pseudocirrhosis onset, tumor characteristics, and chemotherapy use.

Key Points:

  • Pathogenesis involves tumor cell infiltration and potential chemotherapy-induced toxicity.
  • Atypical clinical and imaging features pose diagnostic challenges for clinicians.
  • Pseudocirrhosis negatively impacts patient survival by shortening the median survival time.

Conclusions:

  • Pseudocirrhosis represents a significant challenge in managing patients with malignant tumors and liver metastases.
  • Further research is needed to elucidate the precise factors influencing its development and to optimize patient outcomes.
  • Understanding pseudocirrhosis is crucial for improving diagnosis, treatment, and prognosis in affected individuals.